Amicus Therapeutics Inc (FOLD)
Cost of Revenue
$76.70M
TTM · Period ending: · USD
FOLD Cost of Revenue
Latest reported$76.70Mperiod ending
Latest reported$76.70Mperiod ending
FOLD TTM Cost of Revenue ($0.00 → $76.70M)
TTM cost of revenue
High-resolution chart · PNG
FOLD cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 76,700,000 | |
| 63,092,000 | |
| 55,030,000 | |
| 51,074,000 | |
| 52,943,000 | |
| 49,431,000 | |
| 46,098,000 | |
| 43,951,000 | |
| 37,326,000 | |
| 35,386,000 | |
| 38,876,000 | |
| 37,959,000 | |
| 38,599,000 | |
| 37,066,000 | |
| 35,326,000 | |
| 35,509,000 | |
| 34,466,000 | |
| 36,032,000 | |
| 32,735,000 | |
| 31,031,000 | |
| 31,044,000 | |
| 28,572,000 | |
| 25,769,000 | |
| 24,460,000 | |
| 21,963,000 | |
| 19,362,000 | |
| 18,076,000 | |
| 15,844,000 | |
| 14,404,000 | |
| 12,670,000 | |
| 10,150,000 | |
| 8,076,000 | |
| 6,236,000 | |
| 4,115,000 | |
| 2,669,000 | |
| 1,608,000 | |
| 833,000 | |
| 344,000 | |
| 0 | |
| 8,740,000 | |
| 17,047,000 | |
| 25,214,000 | |
| 31,129,000 | |
| 26,570,000 | |
| 22,375,000 | |
| 17,065,000 | |
| 14,814,000 | |
| 13,571,000 | |
| 13,593,000 | |
| 14,602,000 | |
| 10,938,000 | |
| 8,000,000 | |
| 3,866,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |